Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOcent: Neoadjuvant Chemotherapy vs Letrozole in ER+ Breast Cancer
NCT00963729Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Sep 2008
- Primary completion
- Mar 2010
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of letrozole, fluorouracil, epirubicin, cyclophosphamide, docetaxel in breast cancer, sponsored by Imperial College London. Started Sep 2008; status: completed.
02
Drugs
letrozolefluorouracilepirubicincyclophosphamidedocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00963729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963729.